A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participants

NCT02578550 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide fixed-dose combination (FDC)
DRUG: Emtricitabine/tenofovir alafenamide FDC
DRUG: Darunavir
DRUG: Cobicistat

Sponsor

Janssen Sciences Ireland UC